{
    "additionDate": "2020-01-09T18:32:11Z",
    "biotoolsCURIE": "biotools:trial_designed",
    "biotoolsID": "trial_designed",
    "confidence_flag": "tool",
    "description": "A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies.",
    "editPermission": {
        "type": "public"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Phasing",
                    "uri": "http://edamontology.org/operation_3454"
                },
                {
                    "term": "Standardisation and normalisation",
                    "uri": "http://edamontology.org/operation_3435"
                },
                {
                    "term": "Regression analysis",
                    "uri": "http://edamontology.org/operation_3659"
                }
            ]
        }
    ],
    "homepage": "http://www.trialdesign.org",
    "lastUpdate": "2021-01-16T17:26:53.174647Z",
    "name": "trial designed",
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.1002/SIM.8361",
            "pmid": "31621952"
        }
    ],
    "topic": [
        {
            "term": "Preclinical and clinical studies",
            "uri": "http://edamontology.org/topic_3379"
        },
        {
            "term": "Biomarkers",
            "uri": "http://edamontology.org/topic_3360"
        },
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        },
        {
            "term": "Statistics and probability",
            "uri": "http://edamontology.org/topic_2269"
        },
        {
            "term": "Safety sciences",
            "uri": "http://edamontology.org/topic_3377"
        }
    ]
}